本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Travere Therapeutics, Inc.

21.15
+0.39001.88%
盘后21.150.00000.00%16:20 EDT
成交量:233.38万
成交额:4,890.40万
市值:18.78亿
市盈率:-5.19
高:21.71
开:21.09
低:20.15
收:20.76
数据加载中...
2022/05/12

重要事件披露

8-K - Current report
2022/05/05

重要事件披露

8-K - Current report
2022/05/05

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/04/20

重要事件披露

8-K - Current report
2022/03/21

重要事件披露

8-K - Current report
2022/03/11

重要事件披露

8-K - Current report
2022/03/09

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2022/03/09

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2022/02/24

重要事件披露

8-K - Current report
2022/02/24

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/10

重要事件披露

8-K - Current report
2022/01/06

重要事件披露

8-K - Current report
2021/12/22

重要事件披露

8-K - Current report